Compare Eli Lilly And Co (LLY) vs Vanguard Intermediate Term Corporate Bond ETF (VCIT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eli Lilly And Co vs Vanguard Intermediate Term Corporate Bond ETF — how do they compare? Eli Lilly And Co trades at $1,214.84 (market cap $1.08T), while Vanguard Intermediate Term Corporate Bond ETF trades at $81.18. The key difference: Eli Lilly And Co pays a 0.57% dividend while Vanguard Intermediate Term Corporate Bond ETF pays none. Which is the better fit depends on your goals.
| LLY | VCIT | |
|---|---|---|
Market Cap | $1.08T | — |
Sector | Health | Fixed Income |
52-Week High | $1.24K | $84.82 |
52-Week Low | $639.43 | $81.07 |
Enterprise Value | $1.13T | — |
Dividend Yield | 0.57% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →About Vanguard Intermediate Term Corporate Bond ETF
VCIT tracks the Bloomberg U.S. 5-10 Year Corporate Bond Index, providing exposure to investment-grade debt from industrial, utility, and financial companies. It acts as a middle-ground bond fund, offering higher yields than short-term bonds with less price volatility than long-term corporate debt.
Read more on VCIT →
